A study for a 23 year old woman who takes Mercaptopurine, Pentasa - from FDA reports
130 females aged 23 (±5) who take the same drugs are studied. This is a personalized study for a 23 year old female patient who has Crohn's Disease. The study is created by eHealthMe based on reports from FDA.
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Aug, 06, 2017
130 females aged 23 (±5) who take Mercaptopurine, Pentasa are studied.
Number of reports submitted per year:
Information of the patient in this study:
- Age: 23
- Gender: female
- Conditions: Crohn's Disease
- Drugs taken:
- Mercaptopurine (mercaptopurine)
- Pentasa (mesalamine)
eHealthMe real world results:
Comparison with this patient's adverse outcomes:
- Leukopenia: 0 (0% of females aged 23 (±5) who take the drugs)
As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea
- Leukopenia in Crohn's Disease: 31 (0.25% of females aged 23 (±5) who have Crohn's Disease)
As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea
- Leukopenia in Mercaptopurine: 7 (1.18% of females aged 23 (±5) who take Mercaptopurine)
- Leukopenia in drugs with ingredients of Mercaptopurine: 18 (2.46% of females aged 23 (±5) who take drugs with ingredients of mercaptopurine)
- Leukopenia in Pentasa: 7 (0.85% of females aged 23 (±5) who take Pentasa)
- Leukopenia in drugs with ingredients of Pentasa: 11 (0.46% of females aged 23 (±5) who take drugs with ingredients of mesalamine)
Most common drug interactions over time
Top conditions involved for these people *:
- Birth Control (7 people, 5.38%)
- Insomnia (5 people, 3.85%)
- Migraine (4 people, 3.08%)
- Depression (4 people, 3.08%)
- Hypersensitivity (3 people, 2.31%)
Top co-used drugs for these people *:
- Humira (58 people, 44.62%)
- Prednisone (26 people, 20.00%)
- Remicade (22 people, 16.92%)
- Calcium (12 people, 9.23%)
- Cimzia (9 people, 6.92%)
* Some reports may have incomplete information.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Subscribe to the study: get notified of updates to the study.
You can also:
Expand the study to include reports from both FDA and eHealthMeExpand this study to include FDA and eHealthMe reports
What are the drugs?
- Mercaptopurine has active ingredients of mercaptopurine. It is often used in crohn's disease. (latest outcomes from Mercaptopurine 9,797 users)
- Pentasa has active ingredients of mesalamine. It is often used in crohn's disease. (latest outcomes from Pentasa 11,713 users)
What are the conditions?
- Crohn's disease (condition that causes inflammation of the gastrointestinal tract) can be treated by Humira, Remicade, Pentasa, Prednisone, Imuran (latest reports from 168,116 Crohn's disease patients)
What are the symtoms?
- Leukopenia (less number of white blood cells in blood) has been reported by people with hepatitis c, schizophrenia, high blood pressure, rheumatoid arthritis, multiple myeloma (latest reports from 27,520 Leukopenia patients).
Could your drugs cause:
Could your conditions cause:
Can you answer these questions?
You may be interested in these reviews
I'm here bc my uncle very recently was diagnosed w/prostate cancer & is sure that mercaptopurine is the culprit. He has Crohn's & his doctor told him to double his dose 2 years ago. I'm just looking for others who may have had a similar experience as I know this is troubling him a great deal & I ...